HIV/HTLV co-infection: Frequency and epidemiological characteristics among patients admitted to an Italian hospital

Infection

Volumn 31, Issue 3, 2003, Pages 172-173

  Quiros Roldan, Eugenia ^a   Moretti, Francesca ^a   Torti, C ^a   Casari, S ^a   Castelli, F ^a   Beltrame, A ^a   Carosi, G ^a  

^a Ospedali Civili   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; EPIDEMIOLOGICAL DATA; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORBIDITY; OUTPATIENT; PREVALENCE; VIRUS TRANSMISSION;

EID: 0038454737     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-003-3122-5     Document Type: Article

References (15)

1. Tajima K: Worldwide distribution of HTLV. Jpn J Cancer Res 1998; 89: inside front cover.
2. Robert-Guroff M, Weiss SH, Giron JA, Jennings AM, Ginzburg HM, Margolis IB, Blattner WA, Gallo RC: Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from AIDS endemic region. JAMA 1986; 255: 3133-3137.
3. Bessinger R, Beilke M, Kissinger P, Jarrott C, Tabak F: Retroviral coinfections at a New Orleans HIV outpatient clinic. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 67-71.
4. Etzel A, Shibata GY, Rozman M, Jorge ML, Damas C, Segurado A: HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: seroprevalence and risk factors. J Acquir Immune Defic Syndr 2001; 26: 185-190.
5. Melo J, Beby-Defaux A, Faria C, Guiraud G, Folgosa E, Barreto A: HIV and HTLV prevalences among women seen for sexually transmitted diseases or pregnancy follow-up in Maputo, Mozambique. J Acquir Immune Defic Syndr 2000; 23: 203-204.
6. Ades A, Parker S, Walker J, Edginton M, Taylor G, Weber J: HTLV infection in pregnant women in the United Kingdom: population study. BMJ 2000; 320: 1497-1501.
7. CDC: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Mortality Morbidity Weekly Epidemiological Records 1992; 41 (RR-17): 1-19.
8. Safaeian M, Wilson L, Taylor E, Thomas D, Vlahov D: HTLV-II and bacterial infections among IDUs. J Acquir Immune Defic Syndr 2000; 24: 483-487.
9. Castilla J, Pachon I, Gonzalez MP, Amela C, Munoz L, Tello O, Noguer I, De Ory F, Leon P, Alonso A, Gil F, Garcia-Saiz A: Seroprevalence of HIV and HTLV in a representative sample of Spanish population. Epidemiol Infect 2000; 125: 159-162.
10. Biggar RJ, Neequaye JE, Neequaye AR, Ankra-Badu GA, Levine PH, Manns A, Taylor M, Drummond J, Waters D: The prevalence of antibodies to the HTLV in Ghana, West Africa. AIDS Res Hum Retroviruses 1993; 9: 505-511.
11. Louisiriotchanakul S, Thongput A, Khamboonruang C, Taylor GP, Kunstandter P: No evidence of HTLV infection among the Hmong people of northern Thailand or IDU in Bangkok. J Acquir Immune Defic Syndr 2000; 23: 441-442.
12. McIntyre PG, Hill D, Appleyard K, Taylor A, Hutchinson S, Goldberg D: Prevalence of antibodies to HCV, HIV and HTLV in IDU in Tayside, Scotland, 1993-7. Epidemiol Infect 2001; 126: 97-101.
13. Guimaraes ML, Bastos FI, Telles PR, Galvao-Castro B, Diaz RS, Bongertz V, Morgado MG: Retrovirus infections in a sample of IDU in Rio de Janeiro city, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II. J Clin Virol 2001; 21: 143-151.
14. Varvier E, Alexander S, Forbis R, Lazzarin A: HTLV seroreactivity in Italian IDU is primarily due to HTLV-II infection. JAMA 1991; 265: 597.
15. Toro C, Machuca A, Rodes B, Soriano V: HTLV infection in Spain. 1st IAS Conference on HIV Pathogenesis and Treatment. Buenos Aires July 2001. Abstr. no. 364.